Cargando…
Clinicopathological significance and potential drug target of RUNX3 in breast cancer
BACKGROUND: Previous reports indicate that RUNX3 is a tumor suppressor in several types of human tumors, including breast cancer (BC). However, the correlation between RUNX3 hypermethylation and the incidence of BC remains unclear. In this study, we conducted a systematic review and meta-analysis ai...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266273/ https://www.ncbi.nlm.nih.gov/pubmed/25525332 http://dx.doi.org/10.2147/DDDT.S71815 |